Dr. Linda Barlow's lab focuses on understanding how chemotherapy affects taste perception, especially regarding the cancer treatment drugs used for kidney cancer. The research explores how these drugs disrupt the regeneration of taste bud cells, particularly those responsible for sweet taste. The ultimate goal is to find ways to mitigate taste dysfunction in cancer patients, improving their quality of life during treatment.

Dr. Diana M. Cittelly's research focuses on understanding how hormone therapies and radiation can work together to treat aggressive breast cancers, particularly in young women who are at a higher risk of developing brain metastases. Her team studies the role of the hormone estradiol in promoting tumors and how treatments targeting this hormone might improve patient outcomes. By exploring how these therapies affect immune responses in the brain, her lab aims to develop more effective cancer treatments that could be translated from the lab to clinical practice.

Dr. Chad G. Pearson's lab explores how centrioles and centrosomes function as crucial controllers of cellular organization, particularly their roles in cell division and cilia formation. Their research focuses on understanding how disruptions in these structures can lead to diseases like cancer and Down syndrome. This work has broad implications for our understanding of cell behavior and potential therapeutic strategies.

Dr. Matthew J. Sikora's lab focuses on understanding the biology behind certain types of cancers, specifically gynecologic cancers like ovarian cancer and specific breast cancer subtypes such as invasive lobular carcinoma. The lab investigates how genetic variations and molecular factors drive tumor growth, therapy resistance, and health disparities among different populations. Their research aims to reveal the underlying mechanisms of cancer progression and treatment responses, potentially leading to more effective therapies tailored to patient genetics.